Scholarlink

<p>Although biologics used for systemic therapy of dermatological conditions are generally well tolerated, infection complications can still occur depending on the specific substance. Important measures to increase patient adherence to therapy, therefore, include providing appropriate information about the possible occurrence of infections, their prevention, and treatment. For example, in the case of recurrent <i>Candida</i> infections of the skin and mucous membranes under treatment with interleukin (IL)-17 blockers, fluconazole can be administered once a&#xa0;week as recurrence prophylaxis. In cases of increased risk of herpes zoster under systemic therapy with rituximab, mogamulizumab, or anifrolumab, vaccination with the adjuvanted herpes zoster subunit (HZ/su) attenuated vaccine is recommended. This article on infectious complications under systemic therapy with biologics summarizes possible infection prevention measures and treatment strategies.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Biologikatherapie und Infektionen: Behandeln und Vorbeugen

  • 期刊论文

  • 发表日期：

    2026年6月2日

查看全文
  • Galina Balakirski,
  • Pietro Nenoff

摘要

Although biologics used for systemic therapy of dermatological conditions are generally well tolerated, infection complications can still occur depending on the specific substance. Important measures to increase patient adherence to therapy, therefore, include providing appropriate information about the possible occurrence of infections, their prevention, and treatment. For example, in the case of recurrent Candida infections of the skin and mucous membranes under treatment with interleukin (IL)-17 blockers, fluconazole can be administered once a week as recurrence prophylaxis. In cases of increased risk of herpes zoster under systemic therapy with rituximab, mogamulizumab, or anifrolumab, vaccination with the adjuvanted herpes zoster subunit (HZ/su) attenuated vaccine is recommended. This article on infectious complications under systemic therapy with biologics summarizes possible infection prevention measures and treatment strategies.